ANTOINETTE MILLER: Open Payments
NPI 1053854729 · MARION, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,182 in 44 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,182
Food & beverage: $1,182
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $405 |
| Madrigal Pharmaceuticals | 4 | $320 |
| Janssen Biotech, Inc. | 6 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Gilead Sciences, Inc. | 3 | $65 |
| PFIZER INC. | 2 | $44 |
| Ardelyx, Inc. | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Celltrion USA Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: REZDIFFRA, RINVOQ, TREMFYA, LINZESS, ENTYVIO, VELSIPITY, IBSRELA, XIFAXAN.
Industry payments across IL — which companies pay providers there.
